The patient must understand that the treatment addresses clinical needs, and is not a shortcut for muscle growth in healthy individuals. The Bottom Line Peptides can play a role in medical treatments for specific conditions, but their use as performance enhancers carries potentially significant risks and ethical concerns
GLP-1 Receptor agonist was proved by the Action Control Cardiovascular Risk in Diabetes trial (ACCORD) 75% decrease death rate in patients under Exentide treatment
The loss of Medicaid coverage risks making these highly effective drugs available only to societys well-heeled, physicians said
Not a medicine, not a cure
Life Outcomes 1 , 64 (2003)
These results, in addition to the conflicting results of several metabolic studies of fructose in human volunteers, suggest the relationship between fructose and hyperuricemia may be sensitive to factors aside from just the amount of ingested sugar